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134a Sunday, February 26, 2012Hill number (1.3) for this HENA action were undistinguishable from those
of LCA, HENA’s efficacy was significantly larger than that of LCA, with chan-
nel steady-state activity in presence of 150 mM HENA increasing to 200%
of pre-drug values. Remarkably, HENA failed to activate recombinant, b2-,
b3-, or b4-containing BK channels while activating native BK channels in
rat cerebrovascular myocytes (EC50=46 mM). Therefore, HENA selectively
targets b1-containing BK channels. Furthermore, HENA failed to activate
cbv1þb1T169A channels, suggesting it acts via a BK b1 cholane-sensing
site (Bukiya et al., 2008). HENA (3-45 mM) dilated pressurized cerebral ar-
teries of rat and C57BL/6 mouse. Consistent with its higher efficacy on channel
activity, HENA-induced dilation was significantly larger than that of LCA. As
expected, genetic ablation of BK b1 suppressed HENA-induced vasodilation.
Finally, closed cranial window data from anesthesized rats demonstrated that
intracarotid infusion of HENA significantly dilated pial arterioles. This action
was sustained in presence of 4-aminopyridine but totally prevented by paxil-
line, underscoring BK-mediation of HENA-induced in vivo vasodilation.
This study identifies the first selective non-steroid activator of b1-containing
BKs and effective cerebral artery dilator. Supported by R01-HL104631;
R37-AA011560 (AMD).
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Beta Subunit Transmembrane Domains Determine the Differential
Ethanol Responses of b1- vs. b4-Containing BK Channels
Guruprasad Kuntamallappanavar, Aditya K. Singh, Anna N. Bukiya,
Alex M. Dopico.
The University of Tennessee Hlth. Sci. Ctr., Memphis, TN, USA.
Ethanol (10-100 mM) usually decreases the steady-state activity (Po) of vascu-
lar smooth muscle BK channels while increasing Po of neuronal BK channels
(Brodie et al., 2007). Native BK complexes consist of channel-forming a and
tissue-specific, accessory b subunits. Four b subunit types were identified, with
b1 and b4 prevailing in smooth muscle and neurons, respectively (Brenner et
al., 2000). Remarkably, differential expression of b1- vs. b4-containing BK
channels modifies Po adaptation to protracted ethanol exposure (Feinberg-
Zadek et al., 2008; Martin et al., 2008). On the other hand, b1 is necessary
for ethanol to inhibit vascular smooth muscle BK channels and the resulting va-
soconstriction (Bukiya et al., 2009). To begin to address the mechanisms and
protein regions contributing to differential ethanol actions on BK channels,
we expressed channel-forming cbv1 subunits in absence and presence of
b1 or b4. Then, we conducted G/Gmax-V plots from ionic currents in inside-
out patches and evaluated their modification by acute ethanol exposure.
As described for other BK channels (Orio et al., 2002), b1 but not b4 signifi-
cantly reduced cbv1 V0.5 across 1-1,000 mM calcium. Ethanol (50 mM)
decreased homomeric cbv1 V0.5 at low calcium while increasing V0.5 at
high calcium, the ‘‘crossover’’ from current potentiation to inhibition
occurring at 20 mM calcium. This crossover was left-shifted to 2 mM by b1
co-expression but unaltered by b4 co-expression. Therefore, b1 enables
ethanol inhibition of current at calcium levels that are reached near the BK
channel in myocytes. Evaluation of G/Gmax-V plots from currents mediated
by cbv15chimeric b1/b4 demonstrated that ethanol responses of complexes
containing b chimeras that included b1 TM domains mimicked cbv1þwtb1
responses. Conversely, ethanol responses of complexes containing b chimeras
that included b4 TM domains mimicked cbv1þwtb4 responses. Support:R37-
AA011560 (AMD).
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The Action of the Neuroprotective Compound Riluzole on Kv Channels
Johanna Nilsson, Martin Kempka, Peter Arhem.
Dept of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
The mechanism of action of the neuroprotective agent riluzole, clinically used
against amyotrophic lateral sclerosis (ALS), is poorly understood. Studies have
indicated multiple effects on several ion channel types. For instance, Kv1.5 and
Kv3.1 have been reported to be blocked in the closed and inactivated states. In
the present study the effects on Kv1.1, Kv1.3 and Kv2.1 channels expressed in
Xenopus oocytes were studied, using the two-electrode voltage-clamp system.
Riluzole reversibly inhibited the channels in a concentration dependent manner
with IC50 values for fully open channels of 250, 150 and 700 mikroM, respec-
tively. The slow inactivation of Kv1.1 was accelerated and the steady state in-
activation and the peak activation curves were shifted to the left. However, the
corresponding curves for Kv2.1 did not show shifts. The preliminary results of
an kinetic analysis suggest that riluzole blocks both Kv1 channels in the open
state, while the Kv2.1 channel was blocked both in the open and a closed state.
The results do not show a block of inactivated channels, thus suggesting that the
riluzole effects on Kv1.1, Kv1.3 and Kv2.1 may deviate in several respects
from those on Kv1.5 and Kv3.1.672-Pos Board B458
Integrated Structural Biology of the KCNQ1-KCNE3 Complex
Wade D. Van Horn1, CongBao Kang2, Carlos G. Vanoye1,
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KCNQ1 is a voltage-gated potassium channel with key physiological roles in
cardiac repolarization and intestinal and tracheal ion transport. KCNE3 is
a single span integral membrane b subunit that is co-expressed with KCNQ1
in a number of tissues. KCNE3 is required for KCNQ1 trafficking and func-
tional modulation of, KCNQ1 in the basolateral membranes of intestinal and
tracheal epithelia. This study utilizes an integreted functional and structural ap-
proach to probe the mechanism of KCNE3 modulation of KCNQ1. Whole cell
patch clamp electrophysiology of KCNE3 and KCNE3 mutants with various
KCNQ1 and KCNQ4 chimeras give insight into the functional determinants
of modulation. Solution NMR is used to determine the structure of KCNE3
in isotropic bicelles. The functional and structural data are then coupled with
comparative models of the KCNQ1 channel and computational techniques to
generate structural models of the KCNQ1-KCNE3 complex. These atomically
explicit structural models have predictive ability and yet are readily refined
with addition of new functional and/or structural data. This work was supported
by US NIH grant RO1 DC007416.
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The Distal End of Carboxyl-Terminus is Not Essential for the Assembly of
Rat Eag1 Potassium Channels
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The assembly of four pore-forming a-subunits into tetramers is a prerequisite
for the formation of functional Kþ channels. A short carboxyl assembly domain
(CAD) in the distal end of the cytoplasmic carboxyl-terminus has been impli-
cated in the assembly of Eag a-subunits, a subfamily of the ether-a`-go-go Kþ
channel family. The precise role of CAD in the formation of Eag tetrameric
channels, however, remains unclear. Moreover, it has not been determined
whether other protein regions also contribute to the assembly of Eag subunits.
We addressed these questions by studying the biophysical properties of a series
of different rat Eag1 (rEag1) truncation mutants. Two truncation mutants with-
out CAD (K848X & W823X) yielded functional phenotypes similar to those
for wild-type (WT) rEag1 channels. Furthermore, non-functional rEag1 trunca-
tion mutants lacking the distal region of the carboxyl-terminus displayed sub-
stantial dominant-negative effects on the functional expression of WT as well
as K848X and W823X channels. Our co-immunoprecipitation studies further
revealed that truncation mutants containing no CAD indeed displayed signifi-
cant association with rEag1-WT subunits. Finally, surface biotinylation and
protein glycosylation analyses demonstrated that progressive truncations of
the carboxyl-terminus resulted in aggravating disruptions of membrane traf-
ficking and glycosylation of rEag1 proteins. Overall, our data suggest that
the distal carboxyl-terminus, including CAD, is dispensable for the assembly
of rEag1 Kþ channels, but may instead be essential for ensuring proper protein
biosynthesis. We propose that the S6 segment and the proximal carboxyl-
terminus may constitute the principal subunit recognition site for the assembly
of rEag1 channels.
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14-3-3 is the Binding Partner of the Voltage-Gated Eag Potassium Channel
Po-Hao Hsu1, Pei-Yu Chang2, Chau-Ching Chuang1, Shi-Chuen Miaw1,
Chung-Jiuan Jeng2.
1National Taiwan University, Taipei, Taiwan, 2National Yang-Ming
University, Taipei, Taiwan.
The ether-a´-go-go (Eag) potassium (Kþ) channel belongs to the superfamily of
voltage-gated Kþ channel and is widely expressed in various regions of the
brain. In the rat brain, there are two isoforms of Eag proteins, rat Eag1
(rEag1) and rat Eag2 (rEag2), sharing a high sequence homology. Despite
their abundance in the brain, the precise neurophysiological significance of
Eag channels remains unclear. In order to gain insight into the function of
rEag1 channels in the brain, we have used yeast two-hybrid screening to
identify rEag1-interacting proteins from the rat brain cDNA library. One of
the clones we identified is 14-3-3, which belongs to a small acidic protein
family and is abundantly expressed in the brain. We have performed the co-
immunoprecipitation, GST pull-down assay, and immunofluorescence staining
to confirm the interactions between rEag1 and 14-3-3. Furthermore, we demon-
strated that 14-3-3 reduced the functional expression of rEag1 Kþ currents but
Sunday, February 26, 2012 135afailed to affect the channel’s total protein level and membrane trafficking.
Our data suggest that 14-3-3 is a novel modulator of rEag1 channels in the
brain.
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Membrane ion channels participate in cancerous processes such as prolifera-
tion, migration and invasion, which contribute to metastasis. Increasing evi-
dence indicates that voltage-dependent Kþ (Kv) channels are involved in the
proliferation of many types of cells, including tumor cells. Kv channels have
generated immense interest as a promising tool for developing new anti-
tumor therapies. Therefore, the identification of potential biomarkers and
therapeutic targets in specific cancers is an important prerequisite for the treat-
ment. Since Kv1.3 and Kv1.5 are involved in the proliferation of many mam-
malian cells, we aimed to study the expression of Kv1.3 and Kv1.5 in a plethora
of human cancers. Thus, tissue from breast, stomach, kidney, bladder, lung,
skin, colon, ovary, pancreas, brain, lymph node, skeletal muscle and some of
their malignant counterparts have been analyzed. Whereas Kv1.3 expression
was either decreased or did not change in most tumors, Kv1.5 was overex-
pressed. However, the presence of Kv1.3 was mostly associated with inflamma-
tory lymphoplasmocytic cells. Independent of the suitability of individual
channels as therapeutic targets, the identification of a Kv phenotype from tumor
specimens could have a diagnostic value of its own. Our results demonstrate
that Kv1.5, and to some extent Kv1.3, are aberrantly expressed in a number
of human cancers. These channels could serve both as novel markers of the
metastatic phenotype and as potential new therapeutic targets. The concept
of Kv channels as therapeutic targets or prognostic biomarkers attracts increas-
ing interest and warrants further investigation.
Supported by the Ministerio de Ciencia e Innovacio´n (MICINN), Spain
(BFU2005-00695, BFU2008-00431 and CSD2008-00005).
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A Model of b1-Adrenergic Regulation of L-Type Ca2D Current and
Ryanodine Receptors in Mouse Ventricular Myocytes
Maria V. Shorina, Vladimir E. Bondarenko.
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Mathematical modeling protein signaling networks is one of the most rapidly
developing fields of science. This includes creation and investigation of the
models for protein signaling systems in the heart cells. b1-adrenergic signal-
ing system is one of the most important systems in cardiac myocytes. We de-
veloped an experimentally-based mathematical models of b1-adrenergic
regulation of L-type Ca2þ current and ryanodine receptors in mouse ventric-
ular myocytes. The model includes several modules and describes signal
transduction in the cells. In the model, b1-adrenergic receptors (b1-ARs) are
stimulated by application of b1-adrenergic agonist isoproterenol. Activation
of b1-ARs in turn activates Gs proteins, Gsa subunit of which subsequently
stimulates cyclic AMP (cAMP) synthesis by adenylyl cyclases. cAMP further
activates protein kinase A (PKA) holoenzyme and dissociates PKA catalytic
subunit from regulatory subunit. cAMP is degraded by phosphodiesterases
(PDEs) that can be inhibited by 3-isobutyl-1-methylxanthine (IBMX). Inhibi-
tion of PDEs by IBMX leads to an increase in cAMP level and more profound
stimulation of PKA. PKA is also regulated by heat-stable protein kinase inhib-
itor. b1-ARs are desensitized by b-adrenergic receptor kinase-1 and by cata-
lytic subunit of PKA that creates negative feedback for this signaling
pathway. PKA phosphorylates L-type Ca2þ channel, which results in an
increase of channel’s opening probability and current amplitude. Phosphory-
lation is removed by protein phosphatases 1 and 2A. We developed a Markov
model for L-type Ca2þ channel that consists of two parallel activation-
inactivation pathways for non-phosphorylated and phosphorylated states.
There are also transitions between corresponding non-phosphorylated and
phosphorylated states in the model (closed, open, or inactivated states).
Similar approach was applied to the Markov model development for ryano-
dine receptors. Both models reproduced experimentally observed behavior
of the channels.677-Pos Board B463
Modulation of Cav2.2 Channels via Activation of Human GABAB Recep-
tors Expressed in HEK293 Cells by Analgesic a-Conotoxins
Thuan G. Huynh1,2, Geza Berecki1, David J. Adams1.
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Numerous G protein-coupled receptors, including the GABAB receptor
(GABABR), provide negative feedback to modulate the activity of neuronal
(N)-type voltage-gated calcium channels (Cav2.2), which play a critical role
in nociception. We have previously shown that analgesic a-conotoxins indi-
rectly inhibit Cav2.2 channels via GABABR activation in mammalian dorsal
root ganglion neurons (1). We reconstituted GABABR-mediated modulation
of stably expressed CaV2.2 channels (a1, a2d and b3) in HEK293 cells, co-
transfected with cDNAs of cloned human GABABR subunits. GABABR ex-
pression was demonstrated using receptors labelled with fluorescent antibodies
against the epitope tags of GABAB1 and GABAB2 subunits. Modulation of
Cav2.2 by the agonists GABA and baclofen, and the a-conotoxins Vc1.1 and
RgIA was studied using the whole-cell recording configuration of the patch
clamp technique. Voltage-dependent Ba2þ currents were inhibited by baclofen,
GABA and a-conotoxins Vc1.1 and RgIA in HEK293 cells transfected with
Cav2.2 and GABABRs but not in cells transfected with Cav2.2 alone. In the
presence of the GABABR, the biophysical properties of the Cav2.2 channels,
including the current-voltage relationship, and activation and steady-state inac-
tivation curves, were unchanged. The concentration-response relationships
obtained for inhibition of Cav2.2 by baclofen, GABA, RgIA, Vc1.1, and
cyclized Vc1.1 resulted in half-maximal inhibitory concentrations (IC50) of
3 mM, 68 nM, 130 nM, 120 nM and 10 nM, respectively. The inhibition by
baclofen and GABA could be reversed by a depolarizing prepulse to þ80 mV,
whereas the effect of the a-conotoxins was slower and unaffected by a prepulse,
suggesting the involvement of a voltage-independent pathway. Taken together,
HEK293 cells provide a suitable expression system to study GABABR modu-
lation of Cav2.2 channels and confirm the role of GABABRs in mediating the
effects of analgesic a-conotoxins.
1. Callaghan et al. (2008) J. Neurosci. 28:10943-51.
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Regulators of G-protein signaling (RGS) are GTPase activating proteins (GAP)
that reduce response amplitudes of activated G-protein coupled receptors
(GPCRs). We discovered that, although RGS proteins drastically accelerate
kinetics of GPCR-coupled Kþ currents (GIRK), they actually increased
amplitudes of inhibitory neurotransmitter-evoked GIRK currents. The RGS-
Box domain alone is sufficient for stimulation of transmitter activation of
Kþ currents, but its membrane association enhances the efficiency of stimula-
tion. Moreover, RGS4 mutants with compromised GAP activity still augment
GPCR-GIRK coupling. Among the pertussis toxin sensitive G-proteins, we
found that RGS4 selectively stimulates G alpha-o to maintain robustness of
GPCR-GIRK coupling. Opposing actions of RGS proteins thus both stimulate
and inhibit G-proteins to modulate ultimate amplitudes of transmitter-induced
GIRK currents and to differentiate signal intensity coupled to various G-protein
isoforms.
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Active Site Hydration and Water Diffusion in Cytochrome P450Cam:
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Cytochrome P450s are essential hemoprotein monooxygenases that catalyze
a variety of biochemical processes including drug metabolism, lipid and steroid
biosynthesis, and degradation of pollutants. As an enzyme from Pseudomonas
putida that catalyzes the regio- and stereo-specific hydroxylation of camphor,
cytochrome P450cam has long served as a model system for studying P450s.
Water molecules are known to play an important role in the enzymatic activity
and must be able to enter and exit the active site of P450cam. Here long-
timescale molecular dynamics (MD) simulations (300 ns) are performed on
both the apo- and camphor-bound P450cam. Water diffusion into and out of
